ZA200303251B - Disinfection through packaging. - Google Patents
Disinfection through packaging. Download PDFInfo
- Publication number
- ZA200303251B ZA200303251B ZA200303251A ZA200303251A ZA200303251B ZA 200303251 B ZA200303251 B ZA 200303251B ZA 200303251 A ZA200303251 A ZA 200303251A ZA 200303251 A ZA200303251 A ZA 200303251A ZA 200303251 B ZA200303251 B ZA 200303251B
- Authority
- ZA
- South Africa
- Prior art keywords
- packaging
- light
- laser
- disinfection
- present
- Prior art date
Links
- 238000004806 packaging method and process Methods 0.000 title claims description 466
- 238000004659 sterilization and disinfection Methods 0.000 title claims description 274
- 238000000034 method Methods 0.000 claims description 267
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 221
- 239000007789 gas Substances 0.000 claims description 143
- 230000005855 radiation Effects 0.000 claims description 127
- 239000007788 liquid Substances 0.000 claims description 123
- 230000003287 optical effect Effects 0.000 claims description 96
- 239000000047 product Substances 0.000 claims description 89
- 239000007787 solid Substances 0.000 claims description 80
- 230000001954 sterilising effect Effects 0.000 claims description 74
- 239000000126 substance Substances 0.000 claims description 73
- 238000004519 manufacturing process Methods 0.000 claims description 67
- 241000894007 species Species 0.000 claims description 60
- 230000001473 noxious effect Effects 0.000 claims description 57
- 239000003570 air Substances 0.000 claims description 54
- 230000006378 damage Effects 0.000 claims description 54
- 239000005022 packaging material Substances 0.000 claims description 51
- 235000012206 bottled water Nutrition 0.000 claims description 43
- 238000009826 distribution Methods 0.000 claims description 43
- 230000008569 process Effects 0.000 claims description 43
- 239000011521 glass Substances 0.000 claims description 37
- 239000000463 material Substances 0.000 claims description 35
- 230000000694 effects Effects 0.000 claims description 34
- 150000001875 compounds Chemical class 0.000 claims description 33
- 210000000987 immune system Anatomy 0.000 claims description 33
- 229920000642 polymer Polymers 0.000 claims description 32
- 230000003595 spectral effect Effects 0.000 claims description 29
- 239000002775 capsule Substances 0.000 claims description 28
- 238000010494 dissociation reaction Methods 0.000 claims description 28
- 230000005593 dissociations Effects 0.000 claims description 28
- 230000003647 oxidation Effects 0.000 claims description 28
- 238000007254 oxidation reaction Methods 0.000 claims description 28
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 28
- 238000002360 preparation method Methods 0.000 claims description 27
- 238000012545 processing Methods 0.000 claims description 27
- 230000000249 desinfective effect Effects 0.000 claims description 26
- 241000282414 Homo sapiens Species 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 25
- 238000012384 transportation and delivery Methods 0.000 claims description 25
- 230000005540 biological transmission Effects 0.000 claims description 24
- 230000001427 coherent effect Effects 0.000 claims description 24
- 230000005012 migration Effects 0.000 claims description 23
- 238000013508 migration Methods 0.000 claims description 23
- 230000010076 replication Effects 0.000 claims description 23
- 230000002779 inactivation Effects 0.000 claims description 22
- 230000001965 increasing effect Effects 0.000 claims description 22
- 238000010521 absorption reaction Methods 0.000 claims description 21
- 239000000835 fiber Substances 0.000 claims description 21
- 239000006041 probiotic Substances 0.000 claims description 20
- 230000009467 reduction Effects 0.000 claims description 20
- 241001465754 Metazoa Species 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 235000000346 sugar Nutrition 0.000 claims description 17
- 231100000331 toxic Toxicity 0.000 claims description 17
- 230000002588 toxic effect Effects 0.000 claims description 17
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 16
- -1 jell Substances 0.000 claims description 16
- 239000011707 mineral Substances 0.000 claims description 16
- 235000010755 mineral Nutrition 0.000 claims description 16
- 235000015097 nutrients Nutrition 0.000 claims description 15
- 230000000149 penetrating effect Effects 0.000 claims description 15
- 239000004065 semiconductor Substances 0.000 claims description 15
- 241000196324 Embryophyta Species 0.000 claims description 14
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 14
- 239000013078 crystal Substances 0.000 claims description 14
- 239000001301 oxygen Substances 0.000 claims description 14
- 229910052760 oxygen Inorganic materials 0.000 claims description 14
- 238000006213 oxygenation reaction Methods 0.000 claims description 14
- 230000009471 action Effects 0.000 claims description 13
- 239000003574 free electron Substances 0.000 claims description 13
- 230000006870 function Effects 0.000 claims description 13
- 239000004033 plastic Substances 0.000 claims description 13
- 229920003023 plastic Polymers 0.000 claims description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 239000004698 Polyethylene Substances 0.000 claims description 12
- 230000002708 enhancing effect Effects 0.000 claims description 12
- 238000006722 reduction reaction Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 230000032258 transport Effects 0.000 claims description 12
- 230000001960 triggered effect Effects 0.000 claims description 12
- 239000002131 composite material Substances 0.000 claims description 11
- 230000008878 coupling Effects 0.000 claims description 11
- 238000010168 coupling process Methods 0.000 claims description 11
- 238000005859 coupling reaction Methods 0.000 claims description 11
- 230000000415 inactivating effect Effects 0.000 claims description 11
- 239000000123 paper Substances 0.000 claims description 11
- 229920000515 polycarbonate Polymers 0.000 claims description 11
- 239000004417 polycarbonate Substances 0.000 claims description 11
- 235000013343 vitamin Nutrition 0.000 claims description 11
- 239000004952 Polyamide Substances 0.000 claims description 10
- 230000035622 drinking Effects 0.000 claims description 10
- 235000020188 drinking water Nutrition 0.000 claims description 10
- 239000003651 drinking water Substances 0.000 claims description 10
- 230000003993 interaction Effects 0.000 claims description 10
- 229920002647 polyamide Polymers 0.000 claims description 10
- 229920000728 polyester Polymers 0.000 claims description 10
- 229920000098 polyolefin Polymers 0.000 claims description 10
- 238000005086 pumping Methods 0.000 claims description 10
- 230000004044 response Effects 0.000 claims description 10
- 239000013589 supplement Substances 0.000 claims description 10
- 231100000167 toxic agent Toxicity 0.000 claims description 10
- 239000003440 toxic substance Substances 0.000 claims description 10
- 239000000796 flavoring agent Substances 0.000 claims description 9
- 235000019634 flavors Nutrition 0.000 claims description 9
- 239000013307 optical fiber Substances 0.000 claims description 9
- 230000001590 oxidative effect Effects 0.000 claims description 9
- 230000001360 synchronised effect Effects 0.000 claims description 9
- 208000035484 Cellulite Diseases 0.000 claims description 8
- 239000004677 Nylon Substances 0.000 claims description 8
- 206010049752 Peau d'orange Diseases 0.000 claims description 8
- 230000003197 catalytic effect Effects 0.000 claims description 8
- 230000036232 cellulite Effects 0.000 claims description 8
- 230000002452 interceptive effect Effects 0.000 claims description 8
- 238000007726 management method Methods 0.000 claims description 8
- 229920001778 nylon Polymers 0.000 claims description 8
- 239000002952 polymeric resin Substances 0.000 claims description 8
- 239000003755 preservative agent Substances 0.000 claims description 8
- 230000000306 recurrent effect Effects 0.000 claims description 8
- 229920003002 synthetic resin Polymers 0.000 claims description 8
- 230000008685 targeting Effects 0.000 claims description 8
- 230000003213 activating effect Effects 0.000 claims description 7
- 230000033001 locomotion Effects 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- 229920002125 Sokalan® Polymers 0.000 claims description 6
- 229960001631 carbomer Drugs 0.000 claims description 6
- 231100000481 chemical toxicant Toxicity 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 238000009987 spinning Methods 0.000 claims description 6
- 238000013329 compounding Methods 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 239000010703 silicon Substances 0.000 claims description 5
- 229910052710 silicon Inorganic materials 0.000 claims description 5
- 238000004040 coloring Methods 0.000 claims description 4
- 230000001186 cumulative effect Effects 0.000 claims description 4
- 229910003460 diamond Inorganic materials 0.000 claims description 4
- 239000010432 diamond Substances 0.000 claims description 4
- 238000010894 electron beam technology Methods 0.000 claims description 4
- 239000000178 monomer Substances 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- 239000010409 thin film Substances 0.000 claims description 4
- 238000003491 array Methods 0.000 claims description 3
- 230000033558 biomineral tissue development Effects 0.000 claims description 3
- 125000004122 cyclic group Chemical group 0.000 claims description 3
- 238000009792 diffusion process Methods 0.000 claims description 3
- 231100000673 dose–response relationship Toxicity 0.000 claims description 3
- 239000005454 flavour additive Substances 0.000 claims description 3
- 235000013373 food additive Nutrition 0.000 claims description 3
- 239000002778 food additive Substances 0.000 claims description 3
- 235000013355 food flavoring agent Nutrition 0.000 claims description 3
- 235000020939 nutritional additive Nutrition 0.000 claims description 3
- 230000005693 optoelectronics Effects 0.000 claims description 3
- 238000000527 sonication Methods 0.000 claims description 3
- 230000010354 integration Effects 0.000 claims description 2
- 230000003466 anti-cipated effect Effects 0.000 claims 2
- 230000002040 relaxant effect Effects 0.000 claims 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims 2
- 101100289061 Drosophila melanogaster lili gene Proteins 0.000 claims 1
- 101000620348 Homo sapiens Plasmalemma vesicle-associated protein Proteins 0.000 claims 1
- 102100022427 Plasmalemma vesicle-associated protein Human genes 0.000 claims 1
- VOGVEUAIIKVAOE-VEECZQFMSA-N [(8r,9s,10r,13s,14s,17r)-17-acetyl-6-chloro-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1h-cyclopenta[a]phenanthren-17-yl] acetate;(8r,9s,13s,14s,17r)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-ol Chemical compound C1C[C@]2(C)[C@@](C#C)(O)CC[C@H]2[C@@H]2CCC3=CC(OC)=CC=C3[C@H]21.C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 VOGVEUAIIKVAOE-VEECZQFMSA-N 0.000 claims 1
- 230000002542 deteriorative effect Effects 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 229920001971 elastomer Polymers 0.000 claims 1
- 239000000806 elastomer Substances 0.000 claims 1
- 230000005662 electromechanics Effects 0.000 claims 1
- 235000019249 food preservative Nutrition 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 230000001678 irradiating effect Effects 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000002096 quantum dot Substances 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 description 69
- 239000000306 component Substances 0.000 description 47
- 210000004027 cell Anatomy 0.000 description 37
- 229920002477 rna polymer Polymers 0.000 description 28
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 26
- 108020004414 DNA Proteins 0.000 description 26
- 102000053602 DNA Human genes 0.000 description 26
- 241000894006 Bacteria Species 0.000 description 25
- 238000011282 treatment Methods 0.000 description 24
- 210000001519 tissue Anatomy 0.000 description 20
- 239000000427 antigen Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 108091007433 antigens Proteins 0.000 description 17
- 102000036639 antigens Human genes 0.000 description 17
- 229910052743 krypton Inorganic materials 0.000 description 17
- 235000013361 beverage Nutrition 0.000 description 16
- 239000003086 colorant Substances 0.000 description 16
- 230000007613 environmental effect Effects 0.000 description 16
- 230000028993 immune response Effects 0.000 description 16
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 15
- 241000700605 Viruses Species 0.000 description 14
- 230000008859 change Effects 0.000 description 14
- 230000004907 flux Effects 0.000 description 14
- 210000001744 T-lymphocyte Anatomy 0.000 description 13
- 229910052786 argon Inorganic materials 0.000 description 13
- 239000010836 blood and blood product Substances 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 12
- 210000000265 leukocyte Anatomy 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 125000004429 atom Chemical group 0.000 description 11
- 229940125691 blood product Drugs 0.000 description 11
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 11
- 230000001699 photocatalysis Effects 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 229910052753 mercury Inorganic materials 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 230000003321 amplification Effects 0.000 description 9
- 230000005284 excitation Effects 0.000 description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 9
- 150000002500 ions Chemical class 0.000 description 9
- 238000003199 nucleic acid amplification method Methods 0.000 description 9
- 230000035515 penetration Effects 0.000 description 9
- 238000007146 photocatalysis Methods 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 238000002255 vaccination Methods 0.000 description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical group O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 230000005283 ground state Effects 0.000 description 8
- 238000003384 imaging method Methods 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 238000002834 transmittance Methods 0.000 description 8
- 238000003466 welding Methods 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000007124 immune defense Effects 0.000 description 7
- 210000004698 lymphocyte Anatomy 0.000 description 7
- 230000010287 polarization Effects 0.000 description 7
- 238000005498 polishing Methods 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 239000002028 Biomass Substances 0.000 description 6
- 102000008072 Lymphokines Human genes 0.000 description 6
- 108010074338 Lymphokines Proteins 0.000 description 6
- 229910052779 Neodymium Inorganic materials 0.000 description 6
- 210000003719 b-lymphocyte Anatomy 0.000 description 6
- 238000005452 bending Methods 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 6
- 239000007799 cork Substances 0.000 description 6
- 238000005520 cutting process Methods 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 6
- 210000002865 immune cell Anatomy 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 230000002045 lasting effect Effects 0.000 description 6
- 210000005210 lymphoid organ Anatomy 0.000 description 6
- 210000002540 macrophage Anatomy 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 6
- 150000002894 organic compounds Chemical class 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 238000006555 catalytic reaction Methods 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 208000031513 cyst Diseases 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000008030 elimination Effects 0.000 description 5
- 238000003379 elimination reaction Methods 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 238000005286 illumination Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000002483 medication Methods 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 235000014101 wine Nutrition 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 4
- 238000001720 action spectrum Methods 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 210000000612 antigen-presenting cell Anatomy 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 4
- 230000005465 channeling Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 238000012864 cross contamination Methods 0.000 description 4
- 230000001066 destructive effect Effects 0.000 description 4
- 238000005553 drilling Methods 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 230000005281 excited state Effects 0.000 description 4
- 235000021554 flavoured beverage Nutrition 0.000 description 4
- 230000002070 germicidal effect Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000001165 lymph node Anatomy 0.000 description 4
- 210000001365 lymphatic vessel Anatomy 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 229910052754 neon Inorganic materials 0.000 description 4
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 238000006303 photolysis reaction Methods 0.000 description 4
- 230000015843 photosynthesis, light reaction Effects 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 238000005215 recombination Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- 241001076960 Argon Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 102000013967 Monokines Human genes 0.000 description 3
- 108010050619 Monokines Proteins 0.000 description 3
- JNDMLEXHDPKVFC-UHFFFAOYSA-N aluminum;oxygen(2-);yttrium(3+) Chemical compound [O-2].[O-2].[O-2].[Al+3].[Y+3] JNDMLEXHDPKVFC-UHFFFAOYSA-N 0.000 description 3
- 235000013876 argon Nutrition 0.000 description 3
- 210000003651 basophil Anatomy 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000012503 blood component Substances 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 230000005670 electromagnetic radiation Effects 0.000 description 3
- 210000003714 granulocyte Anatomy 0.000 description 3
- 210000003630 histaminocyte Anatomy 0.000 description 3
- 210000005260 human cell Anatomy 0.000 description 3
- 210000004408 hybridoma Anatomy 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 230000005865 ionizing radiation Effects 0.000 description 3
- 210000002751 lymph Anatomy 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 210000001539 phagocyte Anatomy 0.000 description 3
- 210000004180 plasmocyte Anatomy 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920005644 polyethylene terephthalate glycol copolymer Polymers 0.000 description 3
- 230000000529 probiotic effect Effects 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- 238000006862 quantum yield reaction Methods 0.000 description 3
- 239000010453 quartz Substances 0.000 description 3
- 230000007420 reactivation Effects 0.000 description 3
- 239000010979 ruby Substances 0.000 description 3
- 229910001750 ruby Inorganic materials 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000011343 solid material Substances 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 229940034610 toothpaste Drugs 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 238000009827 uniform distribution Methods 0.000 description 3
- 229910019901 yttrium aluminum garnet Inorganic materials 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- 206010068150 Acoustic shock Diseases 0.000 description 2
- 238000012371 Aseptic Filling Methods 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 241000195628 Chlorophyta Species 0.000 description 2
- 206010011968 Decreased immune responsiveness Diseases 0.000 description 2
- 208000009329 Graft vs Host Disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical compound ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 241001464837 Viridiplantae Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000010352 biotechnological method Methods 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 210000003855 cell nucleus Anatomy 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000005672 electromagnetic field Effects 0.000 description 2
- 210000003979 eosinophil Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000019609 freshness Nutrition 0.000 description 2
- 239000005350 fused silica glass Substances 0.000 description 2
- 208000024908 graft versus host disease Diseases 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000016784 immunoglobulin production Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 238000000752 ionisation method Methods 0.000 description 2
- 210000003563 lymphoid tissue Anatomy 0.000 description 2
- 230000005499 meniscus Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 210000000440 neutrophil Anatomy 0.000 description 2
- 229910052756 noble gas Inorganic materials 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002186 photoactivation Effects 0.000 description 2
- 239000011941 photocatalyst Substances 0.000 description 2
- 238000006552 photochemical reaction Methods 0.000 description 2
- 238000010672 photosynthesis Methods 0.000 description 2
- 230000029553 photosynthesis Effects 0.000 description 2
- 230000000243 photosynthetic effect Effects 0.000 description 2
- VJZLQIPZNBPASX-OJJGEMKLSA-L prednisolone sodium phosphate Chemical compound [Na+].[Na+].O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)COP([O-])([O-])=O)[C@@H]4[C@@H]3CCC2=C1 VJZLQIPZNBPASX-OJJGEMKLSA-L 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 235000013580 sausages Nutrition 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 238000005393 sonoluminescence Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229910019655 synthetic inorganic crystalline material Inorganic materials 0.000 description 2
- 239000011009 synthetic ruby Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 239000012855 volatile organic compound Substances 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 231100000699 Bacterial toxin Toxicity 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000000989 Complement System Proteins Human genes 0.000 description 1
- 108010069112 Complement System Proteins Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 101000702559 Homo sapiens Probable global transcription activator SNF2L2 Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010021460 Immunodeficiency syndromes Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 241000907681 Morpho Species 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 208000007542 Paresis Diseases 0.000 description 1
- 241000255969 Pieris brassicae Species 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 241000221535 Pucciniales Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 238000011579 SCID mouse model Methods 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 230000005867 T cell response Effects 0.000 description 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
- 108010092262 T-Cell Antigen Receptors Proteins 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 241000221561 Ustilaginales Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 210000002534 adenoid Anatomy 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003460 anti-nuclear Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 210000000628 antibody-producing cell Anatomy 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- WZSUOQDIYKMPMT-UHFFFAOYSA-N argon krypton Chemical compound [Ar].[Kr] WZSUOQDIYKMPMT-UHFFFAOYSA-N 0.000 description 1
- 238000012865 aseptic processing Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000009767 bottled carbonated water Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 230000024203 complement activation Effects 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009429 electrical wiring Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 230000002637 immunotoxin Effects 0.000 description 1
- 231100000608 immunotoxin Toxicity 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000001865 kupffer cell Anatomy 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003810 lymphokine-activated killer cell Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 1
- 108700039855 mouse a Proteins 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 208000012318 pareses Diseases 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000001986 peyer's patch Anatomy 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000010895 photoacoustic effect Methods 0.000 description 1
- 230000001443 photoexcitation Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 239000000724 thymus hormone Substances 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/10—Ultraviolet radiation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
- B65B55/02—Sterilising, e.g. of complete packages
- B65B55/12—Sterilising contents prior to, or during, packaging
- B65B55/16—Sterilising contents prior to, or during, packaging by irradiation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
- B65B55/02—Sterilising, e.g. of complete packages
- B65B55/04—Sterilising wrappers or receptacles prior to, or during, packaging
- B65B55/08—Sterilising wrappers or receptacles prior to, or during, packaging by irradiation
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Packages (AREA)
- External Artificial Organs (AREA)
- Materials For Medical Uses (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13928700 | 2000-10-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200303251B true ZA200303251B (en) | 2004-04-26 |
Family
ID=11074760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200303251A ZA200303251B (en) | 2000-10-26 | 2003-04-25 | Disinfection through packaging. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20040219056A1 (fr) |
| EP (1) | EP1334031B1 (fr) |
| JP (1) | JP2004513034A (fr) |
| KR (1) | KR20030077536A (fr) |
| CN (1) | CN1207172C (fr) |
| AT (1) | ATE285941T1 (fr) |
| AU (1) | AU2002212668A1 (fr) |
| BR (1) | BR0115373A (fr) |
| CA (1) | CA2437474A1 (fr) |
| DE (1) | DE60108162T2 (fr) |
| HU (1) | HUP0303580A2 (fr) |
| MA (1) | MA25964A1 (fr) |
| MX (1) | MXPA03003646A (fr) |
| NO (1) | NO20031819L (fr) |
| PL (1) | PL363006A1 (fr) |
| RU (1) | RU2003112209A (fr) |
| WO (1) | WO2002038447A2 (fr) |
| ZA (1) | ZA200303251B (fr) |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2470170A1 (fr) * | 2001-12-13 | 2003-07-31 | Xenon Corporation | Utilisation de lumiere pulsee pour desactiver des bacteries toxiques et pathogenes |
| US7354433B2 (en) * | 2003-02-28 | 2008-04-08 | Advanced Light Technologies, Llc | Disinfection, destruction of neoplastic growth, and sterilization by differential absorption of electromagnetic energy |
| US20050287254A1 (en) * | 2004-06-25 | 2005-12-29 | Radatti Peter V | Apparatus and methods for food processing |
| DE102004036063A1 (de) * | 2004-07-24 | 2006-02-16 | Krones Ag | Vorrichtung und Verfahren zur Plasmabeschichtung/Sterilisation |
| US11246951B2 (en) | 2005-01-31 | 2022-02-15 | S. Edward Neister | Method and apparatus for sterilizing and disinfecting air and surfaces and protecting a zone from external microbial contamination |
| ES2437204T3 (es) * | 2005-01-31 | 2014-01-09 | S. Edward Neister | Procedimiento y aparato para esterilizar y desinfectar aire y superficies, y proteger una zona frente a la contaminación microbiana externa |
| US20060228251A1 (en) * | 2005-04-06 | 2006-10-12 | Jagaji Holdings, Llc | Pulsed high-intensity light sterilization |
| DE102005050167B4 (de) * | 2005-10-19 | 2009-02-19 | Advalytix Ag | Konzentrationsverfahren, Konzentrationsvorrichtung und Reaktionsverfahren |
| SE530018C2 (sv) * | 2006-06-13 | 2008-02-12 | Tetra Laval Holdings & Finance | Metod att sterilisera förpackningar med elektronstrålebestrålning |
| US8157730B2 (en) * | 2006-12-19 | 2012-04-17 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
| US8652040B2 (en) | 2006-12-19 | 2014-02-18 | Valencell, Inc. | Telemetric apparatus for health and environmental monitoring |
| US8323982B2 (en) * | 2007-01-11 | 2012-12-04 | Valencell, Inc. | Photoelectrocatalytic fluid analyte sensors and methods of fabricating and using same |
| WO2008113509A1 (fr) * | 2007-03-16 | 2008-09-25 | Treofan Germany Gmbh & Co. Kg | Emballage pour la stérilisation par uv |
| US8251903B2 (en) | 2007-10-25 | 2012-08-28 | Valencell, Inc. | Noninvasive physiological analysis using excitation-sensor modules and related devices and methods |
| US8125333B2 (en) * | 2008-06-04 | 2012-02-28 | Triton Thalassic Technologies, Inc. | Methods, systems and apparatus for monochromatic UV light sterilization |
| DE102008053131A1 (de) | 2008-10-24 | 2010-04-29 | Fresenius Medical Care Deutschland Gmbh | Verfahren und Anordnung zum Sterilisieren, insbesondere zum Sterilisieren eines Adsorbers |
| US9750462B2 (en) | 2009-02-25 | 2017-09-05 | Valencell, Inc. | Monitoring apparatus and methods for measuring physiological and/or environmental conditions |
| EP3357419A1 (fr) | 2009-02-25 | 2018-08-08 | Valencell, Inc. | Dispositifs de guidage de lumière et dispositifs de surveillance les incorporant |
| US8788002B2 (en) | 2009-02-25 | 2014-07-22 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
| GB0906091D0 (en) * | 2009-04-07 | 2009-05-20 | Snowball Malcolm R | None invasive disinfector |
| US9005530B2 (en) * | 2009-07-09 | 2015-04-14 | Donald Nevin | Compressor with an internal disinfecting UV light source |
| US8692210B2 (en) * | 2009-12-15 | 2014-04-08 | Peter Depew Fiset | Photonic wine processor |
| US9237767B2 (en) * | 2009-12-15 | 2016-01-19 | Peter Depew Fiset | Photonic wine processor |
| US20110288545A1 (en) * | 2010-04-22 | 2011-11-24 | Old Dominion University Research Foundation | Method and Device for Ablation of Cancer and Resistance to New Cancer Growth |
| WO2012009645A1 (fr) * | 2010-07-16 | 2012-01-19 | Perry Felix | Procédé et appareil de désinfection d'articles contenus dans un récipient portatif par exposition à la lumière ultraviolette |
| US8888701B2 (en) | 2011-01-27 | 2014-11-18 | Valencell, Inc. | Apparatus and methods for monitoring physiological data during environmental interference |
| US9360372B2 (en) * | 2011-06-20 | 2016-06-07 | Bae Systems Information And Electronic Systems Integration Inc. | System and method for using a portable near IR LED light source and photogrammetry for boresight harmonization of aircraft and ground vehicle components |
| CN102389583B (zh) * | 2011-06-24 | 2013-11-06 | 深圳大学 | 一种杀菌系统 |
| WO2013016007A2 (fr) | 2011-07-25 | 2013-01-31 | Valencell, Inc. | Appareil et procédés d'estimation de paramètres physiologiques temps-état |
| US9801552B2 (en) | 2011-08-02 | 2017-10-31 | Valencell, Inc. | Systems and methods for variable filter adjustment by heart rate metric feedback |
| CN110013240A (zh) | 2013-01-28 | 2019-07-16 | 瓦伦赛尔公司 | 具有与身体运动脱开的感测元件的生理监测装置 |
| USD734054S1 (en) * | 2013-03-15 | 2015-07-14 | William R. New | Toothbrush and/or razor holder |
| EP2805912B1 (fr) * | 2013-05-21 | 2016-02-03 | Claranor | Dispositif et procédé pour la décontamination d'objets creux tels que des bouchons de récipient au moyen de rayonnements UV |
| EP3003470B8 (fr) | 2013-06-03 | 2017-10-04 | Pulse Biosciences, Inc. | Procédés et dispositifs de stimulation d'une réponse immunitaire à l'aide de champs électriques pulses de très courte durée (nanosecondes) |
| WO2015021072A1 (fr) * | 2013-08-05 | 2015-02-12 | The Regents Of The University Of California | Appareil pour désinfection par uv d'un liquide |
| US9176361B2 (en) * | 2014-03-11 | 2015-11-03 | Sony Corporation | Optical analog to digital converter and method |
| US9538921B2 (en) | 2014-07-30 | 2017-01-10 | Valencell, Inc. | Physiological monitoring devices with adjustable signal analysis and interrogation power and monitoring methods using same |
| EP3151737B1 (fr) | 2014-08-06 | 2022-08-17 | Valencell, Inc. | Modules à capteurs physiologiques optiques avec réduction du bruit de signal |
| US9794653B2 (en) | 2014-09-27 | 2017-10-17 | Valencell, Inc. | Methods and apparatus for improving signal quality in wearable biometric monitoring devices |
| AU2015355241B2 (en) | 2014-12-01 | 2019-10-24 | Pulse Biosciences, Inc. | Nanoelectroablation control and vaccination |
| CN104511032B (zh) * | 2014-12-29 | 2017-04-26 | 中国工程物理研究院流体物理研究所 | 用于医疗器械的转镜扫描式双波段半导体激光灭菌系统 |
| DE102015002795A1 (de) | 2015-03-06 | 2016-09-08 | Khs Corpoplast Gmbh | Maschine und Verfahren zum Herstellen und Befüllen von Behältern |
| US10180248B2 (en) | 2015-09-02 | 2019-01-15 | ProPhotonix Limited | LED lamp with sensing capabilities |
| US10610158B2 (en) | 2015-10-23 | 2020-04-07 | Valencell, Inc. | Physiological monitoring devices and methods that identify subject activity type |
| US10945618B2 (en) | 2015-10-23 | 2021-03-16 | Valencell, Inc. | Physiological monitoring devices and methods for noise reduction in physiological signals based on subject activity type |
| CN105253387A (zh) * | 2015-11-04 | 2016-01-20 | 天津宜诺医药工业设计有限公司 | 物料灭菌装置 |
| US10966662B2 (en) | 2016-07-08 | 2021-04-06 | Valencell, Inc. | Motion-dependent averaging for physiological metric estimating systems and methods |
| US10968704B2 (en) | 2018-02-22 | 2021-04-06 | Saudi Arabian Oil Company | In-situ laser generator cooling system for downhole application and stimulations |
| HUP1800124A1 (hu) * | 2018-04-16 | 2020-01-28 | Viktor Mate | Sugárforrással rendelkezõ berendezés káros mikroorganizmusok elpusztításának elõsegítéséhez, különösen élelmiszerek tartósításának megkönnyítéséhez |
| US10421670B1 (en) * | 2018-07-10 | 2019-09-24 | Louise Wilkie | Humic and fulvic black water based beverage for human consumption |
| US10934511B2 (en) * | 2018-09-06 | 2021-03-02 | Louise Wilkie | Humic and fulvic black water based beverage for human consumption |
| US11231506B2 (en) | 2018-09-14 | 2022-01-25 | Billion Bottle Project | Ultraviolet (UV) dosimetry |
| DE102018124664A1 (de) * | 2018-10-05 | 2020-04-09 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zum Inaktivieren biologisch aktiver Bestandteile innerhalb einer Flüssigkeit |
| US10894937B2 (en) * | 2019-04-07 | 2021-01-19 | Louise Wilkie | Fulvic acid and humic acid mix for alcoholic beverages method and devices |
| EP3756693A3 (fr) * | 2019-06-28 | 2021-05-19 | Tetra Laval Holdings & Finance S.A. | Procédé de suppression d'excès d'un agent de stérilisation d'une toile de matériau d'emballage à base de carton et système associé |
| CN115349206A (zh) * | 2020-02-03 | 2022-11-15 | 努布鲁有限公司 | 长寿命激光二极管封装 |
| US11020502B1 (en) | 2020-05-01 | 2021-06-01 | Uv Innovators, Llc | Ultraviolet (UV) light emission device, and related methods of use, particularly suited for decontamination |
| CN113827258B (zh) * | 2020-06-24 | 2024-05-17 | 浙江天诚电力载波技术有限公司 | 一种基于激光与纳米技术的载波医疗机器人 |
| US11662511B2 (en) | 2020-07-22 | 2023-05-30 | Samsung Electronics Co., Ltd. | Beam expander and method of operating the same |
| JP6896919B1 (ja) * | 2020-08-03 | 2021-06-30 | 株式会社クォークテクノロジー | 殺菌ランプ |
| US11947878B2 (en) * | 2020-11-24 | 2024-04-02 | Triple Ring Technologies, Inc. | Method and apparatus for electron beam processing control |
| CN112722468B (zh) * | 2020-12-28 | 2022-11-29 | 佛山市顺德区保利食品有限公司 | 一种鱼类冷冻食品包装设备传送带上的灭菌装置 |
| CN112966225B (zh) * | 2021-03-22 | 2023-03-31 | 南昌航空大学 | 一种基于正态分布的钢丝绳安全寿命评估方法 |
| US12121621B2 (en) | 2021-07-09 | 2024-10-22 | B/E Aerospace, Inc. | Sanitization systems and methods |
| US11874223B1 (en) | 2022-08-30 | 2024-01-16 | The Goodyear Tire & Rubber Company | Terahertz characterization of a multi-layered tire tread |
| CN116558438B (zh) * | 2023-07-11 | 2023-09-15 | 湖南视觉伟业智能科技有限公司 | 一种吹瓶质量检测装置及方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3817703A (en) * | 1969-03-03 | 1974-06-18 | Filtering Materials Inc | Laser energized sterilization method and apparatus |
| US3672823A (en) * | 1970-03-25 | 1972-06-27 | Wave Energy Systems | Method of sterilizing liquids |
| JPS63307027A (ja) * | 1987-06-08 | 1988-12-14 | Ueno Hiroshi | 密封容器内部の無菌化法 |
| DE3923539A1 (de) * | 1989-07-15 | 1991-01-24 | Karl Fabricius | Aseptische abfuellmaschine fuer lebensmittel |
| JPH0457726A (ja) * | 1990-06-15 | 1992-02-25 | Toppan Printing Co Ltd | 水の殺菌方法および殺菌用部材 |
| GB9107751D0 (en) * | 1991-04-12 | 1991-05-29 | Elopak Systems | Treatment of material |
| JPH05132043A (ja) * | 1991-10-31 | 1993-05-28 | Iwasaki Electric Co Ltd | 容器の殺菌装置 |
| US5768853A (en) * | 1996-02-15 | 1998-06-23 | Purepulse Technologies, Inc. | Deactivation of microorganisms |
| US5925885A (en) * | 1996-05-22 | 1999-07-20 | Purepulse Technologies, Inc. | Parametric control in pulsed light sterilization of packages and their contents |
| BE1010407A4 (fr) * | 1996-07-04 | 1998-07-07 | Undatim Ultrasonics | Procede et installation de traitement des eaux. |
| KR20000062691A (ko) * | 1999-03-01 | 2000-10-25 | 존슨 앤드 존슨 비젼 케어, 인코포레이티드 | 살균방법 |
| US6579495B1 (en) * | 2000-07-27 | 2003-06-17 | Hydro Photon, Inc. | Hand-held ultraviolet water purification system using solid state devices |
| AU2001285398A1 (en) * | 2000-08-04 | 2002-02-18 | Color Kinetics Incorporated | Ultraviolet light emitting diode systems and methods |
-
2001
- 2001-10-26 DE DE60108162T patent/DE60108162T2/de not_active Expired - Fee Related
- 2001-10-26 RU RU2003112209/12A patent/RU2003112209A/ru not_active Application Discontinuation
- 2001-10-26 WO PCT/IL2001/000995 patent/WO2002038447A2/fr active IP Right Grant
- 2001-10-26 MX MXPA03003646A patent/MXPA03003646A/es unknown
- 2001-10-26 JP JP2002540997A patent/JP2004513034A/ja active Pending
- 2001-10-26 US US10/415,142 patent/US20040219056A1/en not_active Abandoned
- 2001-10-26 BR BR0115373-0A patent/BR0115373A/pt not_active Application Discontinuation
- 2001-10-26 EP EP01980884A patent/EP1334031B1/fr not_active Expired - Lifetime
- 2001-10-26 AT AT01980884T patent/ATE285941T1/de not_active IP Right Cessation
- 2001-10-26 PL PL01363006A patent/PL363006A1/xx unknown
- 2001-10-26 AU AU2002212668A patent/AU2002212668A1/en not_active Abandoned
- 2001-10-26 HU HU0303580A patent/HUP0303580A2/hu unknown
- 2001-10-26 CN CNB018213367A patent/CN1207172C/zh not_active Expired - Fee Related
- 2001-10-26 CA CA002437474A patent/CA2437474A1/fr not_active Abandoned
- 2001-10-26 KR KR10-2003-7005858A patent/KR20030077536A/ko not_active Application Discontinuation
-
2003
- 2003-04-23 NO NO20031819A patent/NO20031819L/no not_active Application Discontinuation
- 2003-04-23 MA MA27119A patent/MA25964A1/fr unknown
- 2003-04-25 ZA ZA200303251A patent/ZA200303251B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03003646A (es) | 2005-07-01 |
| HUP0303580A2 (en) | 2004-01-28 |
| CN1482982A (zh) | 2004-03-17 |
| EP1334031B1 (fr) | 2004-12-29 |
| JP2004513034A (ja) | 2004-04-30 |
| ATE285941T1 (de) | 2005-01-15 |
| DE60108162T2 (de) | 2006-01-05 |
| EP1334031A2 (fr) | 2003-08-13 |
| CA2437474A1 (fr) | 2002-05-16 |
| NO20031819L (no) | 2003-06-20 |
| US20040219056A1 (en) | 2004-11-04 |
| MA25964A1 (fr) | 2003-12-31 |
| BR0115373A (pt) | 2004-02-03 |
| AU2002212668A1 (en) | 2002-05-21 |
| DE60108162D1 (de) | 2005-02-03 |
| RU2003112209A (ru) | 2005-01-20 |
| WO2002038447A2 (fr) | 2002-05-16 |
| PL363006A1 (en) | 2004-11-15 |
| WO2002038447A3 (fr) | 2003-01-03 |
| CN1207172C (zh) | 2005-06-22 |
| KR20030077536A (ko) | 2003-10-01 |
| NO20031819D0 (no) | 2003-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1334031B1 (fr) | Desinfection au travers d'un emballage | |
| US20040120844A1 (en) | Advanced oxidation of dangerous chemical and biological sources | |
| IL150914A (en) | A method for hydro-optronio photochemical treatment of liquids | |
| US8125333B2 (en) | Methods, systems and apparatus for monochromatic UV light sterilization | |
| US9630022B2 (en) | Plasmonic assisted systems and methods for interior energy-activation from an exterior source | |
| US4309388A (en) | Ozone sterilizing apparatus | |
| US20090274576A1 (en) | System and method for container sterilization using UV light source | |
| US20030188740A1 (en) | Method for production of enhanced traceable immunizing drinking water and other liquid and gas products, devices for production and use thereof, and use of the enhanced products for immunizing living beings | |
| JP4560870B2 (ja) | プリフォーム殺菌方法及びプリフォーム殺菌装置 | |
| CN107206115A (zh) | 用脉冲电子束和活动反射器灭菌热塑性材料容器的装置和方法 | |
| US20020070358A1 (en) | Carton sterilization method and apparatus | |
| US20030161756A1 (en) | Microdispersion treatment of a protein or pharmaceutical | |
| JP6405348B2 (ja) | 紫外線殺菌方法 |